ED Diabetes Screening and Outpatient Care - Aim 3

Официальное название

Identifying Risk Factors for Poor Glycemic Control Among Emergency Department Patients and Improving Linkage to Outpatient Care

Обзор

This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.

Вмешательства

• Другое Telehealth Bridge Visits
  Patients will be scheduled for a telemedicine visit staffed by a family or internal medicine trained physician who will assess their understanding and answer any questions about the new diagnosis of diabetes, start initial conversations about how to improve their habits around diet and exercise, and discuss medication options for diabetes and, if appropriate, initiate treatment. At the end of the telemedicine visit, providers will attempt to address any difficulties that patients are experiencin
• Другое Standard of Care
  Standard of care currently includes calls from the site's follow-up center to see if patients received their HbA1c result, understood what their result meant, had any problems accessing medications prescribed or any difficulty scheduling an outpatient follow-up visit.

Первичные конечные точки

• Percent of Patients who Complete at least One In-Person Follow-up Outpatient Visit [Срок оценки: Up to Month 6 Post-Diagnosis]

Вторичные конечные точки (3)

• Percent of Patients who Complete at least One Follow-Up Hemoglobin A1C (HbA1c) Test within 6 Months of Diagnosis [Срок оценки: Up to Month 6 Post-Diagnosis]
• Percent of Patients who Complete at least One Follow-Up Hemoglobin A1C (HbA1c) Test within 12 Months of Diagnosis [Срок оценки: Up to Month 12 Post-Diagnosis]
• Percent of Patients who Start on Diabetes Medications within 6 Months of Diagnosis [Срок оценки: Up to Month 6 Post-Diagnosis]

Критерии участия

Критерии включения

• Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
• Residential address in New York City or Long Island
• Primary language is English or Spanish
• Able to provide informed consent

Критерии исключения

• No prior history of diabetes
• No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Организация здравоохранения

Центры проведения

США · 1 центр

• NYU Langone Health — New York

Идентификаторы

NCT: NCT05899023 · 23-00571 · 5R01DK134668

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗